 |
PDBsum entry 1fcz
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Gene regulation
|
PDB id
|
|
|
|
1fcz
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.
|
 |
|
Authors
|
 |
B.P.Klaholz,
A.Mitschler,
D.Moras.
|
 |
|
Ref.
|
 |
J Mol Biol, 2000,
302,
155-170.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
The human retinoic acid receptor (hRAR) belongs to the family of nuclear
receptors that regulate transcription in a ligand-dependent way. The isotypes
RARalpha,beta and gamma are distinct pharmacological targets for retinoids that
are involved in the treatment of various skin diseases and cancers, in
particular breast cancer and acute promyelocytic leukemia. Therefore, synthetic
retinoids have been developed aiming at isotype selectivity and reduced
side-effects. We report the crystal structures of three complexes of the
hRARgamma ligand-binding domain (LBD) bound to agonist retinoids that possess
selectivity either for RARgamma (BMS184394) or for RARbeta/gamma (CD564), or
that are potent for all RAR-isotypes (panagonist BMS181156). The high resolution
data (1.3-1. 5 A) provide a description at the atomic level of the ligand pocket
revealing the molecular determinants for the different degrees of ligand
selectivity. The comparison of the complexes of the chemically closely related
retinoids BMS184394 and CD564 shows that the side-chain of Met272 adopts
different conformations depending on the presence of a hydrogen bond between its
sulfur atom and the ligand. This accounts for their different isotype
selectivity. On the other hand, the difference between the pan- and the RARbeta,
gamma-selective agonist is probably due to a steric discrimination at the level
of the 2-naphthoic acid moiety of CD564. Based on this study, we propose a model
for a complex with the RARgamma-specific agonist CD666 that shows the possible
applications for structure-based drug design of RAR isotype-selective retinoids.
|
 |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Detail of the W*-loop showing the non-planar
peptide linkage between Ser215 and Ala216, and the double
conformation of Ser215 that allows the formation of different
hydrogen bonds for the stabilization of the W*-loop (stereo
view). The s[A]-weighted 2 mF[o] -DF[c] electron density map
(colored in blue) at 1.30 Å resolution is contoured at
1.5s.
|
 |
Figure 3.
Figure 3. The chemical similarity of the RARg-selective
BMS184394 and the RARb,g-selective CD564 allows to attribute
their different selectivity to their respective hydroxyl and
keto groups (stereo views). (a) Final model of the BMS184394
complex depicted with the initial refinement-unbiased
s[A]-weighted mF[o] -F[c] omit map (colored in violet) at 1.47
Å resolution contoured at 3.2s. The protein part is
colored in green and the ligand in red. Although a racemic
mixture has been used in co-crystallization only the
R-enantiomer of BMS184394 is present exhibiting a hydrogen bond
to the Met272 sulfur atom. (b) The CD564 complex with the ligand
fitted to its electron density (s[A]-weighted mF[o] -F[c] omit
map at 1.30 Å resolution contoured at 3.2s, colored in
orange). The protein part is colored in blue and the ligand in
orange. (c) The pocket superposition obtained by a least-squares
fit of the BMS184394 and CD564 complexes illustrates that the
conformation of the Met272 side-chain depends on the interaction
pattern with the ligand. The movement of Met272 is mediated to
Ile389 and Leu386. Note that Ile389 and Ser390 exhibit two
independent conformations for each structure that are depicted
in green and yellow for the BMS184394 complex and in blue and
violet for the CD564 complex.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2000,
302,
155-170)
copyright 2000.
|
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
Enantiomer discrimination illustrated by high-Resolution crystal structures of the human nuclear receptor hrargamma.
|
 |
|
Authors
|
 |
B.P.Klaholz,
A.Mitschler,
M.Belema,
C.Zusi,
D.Moras.
|
 |
|
Ref.
|
 |
Proc Natl Acad Sci U S A, 2000,
97,
6322-6327.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Stereo representation of the ligand-binding
pocket of the crystal structure of the hRAR LBD with
the bound active enantiomer BMS270394 (shown in orange). The
final model is depicted with the ligand fitted to the electron
density map (colored in red) that has been calculated at the
very beginning of the refinement in absence of the ligand. The
[A]-weighted
F[obs] F[calc]
map (18) at 1.59-Å resolution is contoured at 3.2 . Distances
in yellow indicate hydrogen bonds and salt bridges between
ligand and residues, whereas van der Waals contacts are shown in
blue. RAR selectivity
of the ligand is achieved by its hydroxyl group, which forms a
hydrogen bond with the sulfur of Met-272, corresponding to
isoleucines in RAR and . H3, H5,
H10, and H11 indicate helices, and L6/7 the loop between helix 6
and 7.
|
 |
Figure 2.
Fig. 2. Structure of hRAR LBD bound
to the inactive BMS270395 and its comparison with the BMS270394
complex (stereo representations) (A). The BMS270395 complex with
the initial refinement-unbiased [A]-weighted
F[obs] F[calc]
map at 1.67 Å resolution contoured at 3.2 and
colored in violet. The map clearly indicates two possible
positions for the fluorine atom, corresponding to two different
ligand conformations. The up and down orientations of the
fluorine atom have occupancies of 40/60%, respectively (colored
in green and red, pointing to Ile-275 and Ala-234, respectively)
(B). Superposition of the hRAR LBD
complexes of both enantiomers as obtained by a least-squares
fit. The position of the hydroxyl group oxygen is strictly
conserved to maintain the hydrogen bond to Met-272; BMS270395
therefore adopts a conformation different from that observed for
BMS270394 (C). Detailed view of the part of the ligand pocket
where the ligand exhibits unfavorable contacts. The color code
for distances is that of Fig. 1. The fluorine atom exhibits
close contacts for both the up and down orientation, whereas the
salt bridge between the carboxylate group and Arg-278 is weaker
compared with the BMS270394 complex.
|
 |
|
 |
 |
|
Secondary reference #2
|
 |
|
Title
|
 |
Conformational adaptation of agonists to the human nuclear receptor rar gamma.
|
 |
|
Authors
|
 |
B.P.Klaholz,
J.P.Renaud,
A.Mitschler,
C.Zusi,
P.Chambon,
H.Gronemeyer,
D.Moras.
|
 |
|
Ref.
|
 |
Nat Struct Biol, 1998,
5,
199-202.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
Secondary reference #3
|
 |
|
Title
|
 |
Crystal structure of the rar-Gamma ligand-Binding domain bound to all-Trans retinoic acid.
|
 |
|
Authors
|
 |
J.P.Renaud,
N.Rochel,
M.Ruff,
V.Vivat,
P.Chambon,
H.Gronemeyer,
D.Moras.
|
 |
|
Ref.
|
 |
Nature, 1995,
378,
681-689.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
|
|
|
 |